Literature DB >> 11596964

Effect of absorbable topical hemostatic agents on the relaxation time of blood: an in vitro study with implications for postoperative magnetic resonance imaging.

M Spiller1, M S Tenner, W T Couldwell.   

Abstract

OBJECT: Absorbable topical hemostatic agents are commonly used in neurosurgery. In this study the authors examine the longitudinal relaxation time (T1) of blood in contact with these agents over time, measured in vitro, to determine if their presence could affect the interpretation of postoperative magnetic resonance (MR) images.
METHODS: Coagulated and anticoagulated blood were used, both oxygenated and deoxygenated. The effects of a collagen-based agent (Collastat) and a cellulose-based agent (Surgicel) on the pH and T1 values of blood and on those of saline (used as a control) were investigated. The T1 was measured as a function of magnetic field strength and time by using a field-cycling relaxometer. This instrument measures 1/T1, the rate of T1, from which the T, value is computed. The T1 values of blood were compared with those of hemostat-induced blood clots and with those of both gray and white matter of the brain. Signal changes on T1-weighted MR images were predicted on the basis of altered T, values in vitro. Postoperative images were visually examined for the predicted changes. With the addition of Surgicel, blood had decreased pH and significantly shortened T1 at all fields, essentially within minutes, although it affected the T1 of saline only minimally. The effect of Surgicel increasingly shortened the T1 for 4 days in oxygenated blood. Collastat had no significant effect. The presence of some paramagnetic methemoglobin in Surgicel-induced clots was demonstrated using the relaxometer at a time when diamagnetic oxyhemoglobin would be present in naturally occurring blood clots. A bright signal that could mimic residual tumor on contrast-enhanced images was predicted and confirmed on postoperative T1-weighted MR images obtained in patients in whom Surgicel lined the tumor bed. It was not present in cases in which Surgicel was not used.
CONCLUSIONS: Surgicel alters the appearance of early postoperative MR images. To avoid misinterpretation, clinicians should be aware of this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11596964     DOI: 10.3171/jns.2001.95.4.0687

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

Review 1.  Clinical benefits and risk analysis of topical hemostats: a review.

Authors:  Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

2.  Haemostatic material (Surgicel®) mimicking residual tumour: magnetic resonance imaging findings in operated pediatric neuro-oncology cases.

Authors:  Serena Staglianò; Felice D'Arco; Ai Peng Tan; Owase Jeelani; Giovanni Morana; Kshitij Mankad
Journal:  Quant Imaging Med Surg       Date:  2018-10

Review 3.  Single-dose contrast agent for intraoperative MR imaging of intrinsic brain tumors by using ferumoxtran-10.

Authors:  Matthew A Hunt; Attila G Bagó; Edward A Neuwelt
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

4.  Imaging features of a gelatin-thrombin matrix hemostatic agent in the intracranial surgical bed: a unique space-occupying pseudomass.

Authors:  K O Learned; S Mohan; I Z Hyder; L J Bagley; S Wang; J Y Lee
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-01       Impact factor: 3.825

5.  Reactive gliosis mimicking tumor recurrence - a case series documenting MRI abnormalities and neuropathological correlates.

Authors:  Hugh Kearney; Jane Cryan; Alan Beausang; Seamus Looby; Francesca M Brett
Journal:  Clin Neuropathol       Date:  2018 May/Jun       Impact factor: 1.368

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.